BioNTech SE (BNTX) Change in Intangibles (2024 - 2025)

BioNTech SE's (BNTX) quarterly Change in Intangibles came in at $1.3 million in Q4 2025, up 104.89% year-on-year from $624941.5 in Q4 2024, and up 140.57% quarter-over-quarter from -$3.2 million in Q3 2025.

BioNTech SE (BNTX) Change in Intangibles (2024 - 2025) Analysis & Trends

BioNTech SE has disclosed Change in Intangibles across 2 years of filings, most recently posting $1.3 million for Q4 2025.

  • Change in Intangibles for Q4 2025 came in at $1.3 million, up 104.89% year-over-year; the trailing twelve-month figure through Dec 2025 was -$31.6 million (changed N/A YoY), and the FY2025 annual result was -$648.4 million, down 265.97% from the prior year.
  • Change in Intangibles came in at $1.3 million for Q4 2025 at BioNTech SE, up from -$3.2 million in the prior quarter.
  • In the past five years, Change in Intangibles ranged from a high of $1.3 million in Q4 2025 to a low of -$56.8 million in Q2 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Intangibles (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -2.96 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - -
10 BioNTech SE 27.38 Bn 10.07 Bn 668.28 Mn 1.28 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 1.28 Mn
Dec 31, 2025 1.28 Mn
Sep 30, 2025 -3.16 Mn
Sep 30, 2025 -3.16 Mn
Jun 30, 2025 -3.51 Mn
Jun 30, 2025 -3.51 Mn
Dec 31, 2024 -26.18 Mn
Dec 31, 2024 -26.18 Mn
Sep 30, 2024 -11.20 Mn
Sep 30, 2024 -11.20 Mn
Jun 30, 2024 -56.75 Mn
Jun 30, 2024 -56.75 Mn